Suppression of tumorigenicity, but not anchorage independence, of human cancer cells by new candidate tumor suppressor gene CapG

Oncogene

Volumn 25, Issue 56, 2006, Pages 7373-7380

  Watari, A ^a   Takaki, K ^a   Higashiyama, S ^a   Li, Y ^a   Satomi, Y ^b   Takao, T ^b   Tanemura, A ^b   Yamaguchi, Y ^b   Katayama, I ^b   Shimakage, M ^c   Miyashiro, I ^d   Takami, K ^d   Kodama, K ^d   Yutsudo, M ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

CapG; Gastric cancer; Lung cancer; Multistep tumorigenesis; Tumor suppressor gene

Indexed keywords

COMPLEMENTARY DNA; PROTEIN; PROTEIN CAPG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CAPG GENE; CARCINOGENICITY; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CULTURE MEDIA; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, NUDE; MICROFILAMENT PROTEINS; NEOPLASMS; NUCLEAR PROTEINS;

MUS MUSCULUS;

EID: 33845220334     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209732     Document Type: Article

References (16)

1. Akagi T, Shishido T, Murata K, Hanafusa H. (2000). Proc Natl Acad Sci USA 97: 7290-7295.
2. Dabiri GA, Young CL, Rosenbloom J, Southwick FS. (1992). J Biol Chem 267: 16545-16552.
3. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al (2002). Nature 417: 949-954.
4. De Corte V, Van Impe K, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J et al. (2004). J Cell Sci 117: 5283-5292.
5. Hahn WC, Weinberg RA. (2002). Nat Rev Cancer 2: 331-341.
6. Lal A, Lash AE, Altschul SF, Velculescu V, Zhang L, McLendon RE et al. (1999). Cancer Res 59: 5403-5407.
7. Oka K, Tomonaga Y, Nakazawa T, Ge H-Y, Bengtsson U, Stanbridge EJ et al. (1999). Genes, Chromosome Cancer 26: 47-53.
8. Pellieux C, Desgeorges A, Pigeon CH, Chambaz C, Yin H, Hayoz D et al. (2003). J Biol Chem 278: 29136-29144.
9. Prendergast GC, Ziff EB. (1991). EMBO J 10: 757-766.
10. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. (2002). Nature 418: 934.
11. Rajogopalan H, Nowak MA, Vogelstein B, Lengauer C. (2003). Nat Rev Cancer 3: 695-701.
12. Sagawa N, Fujita H, Banno Y, Nozawa Y, Katoh H, Kuzumaki N. (2003). Br J Cancer 88: 606-612.
13. Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D. (2004). Cell Mol Life Sci 61: 2614-2623.
14. Tanaka M, Mullauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K et al. (1995). Cancer Res 55: 3228-3232.
15. Van Ginkel PR, Gee RL, Walker TM, Hu D-N, Heizmann CW, Polans AS. (1998). Biochim Biophys Acta 1448: 290-297.
16. Yu F-X, Johnston PA, Sudhof TC, Yin HL. (1990). Science 250: 1413-1415.